Role of animal models in HCM research (Q37766184)

22 August 2017

1 reference

title

Role of animal models in HCM research (English)

1 reference

22 August 2017

author

Christopher Semsarian

series ordinal

2

object named as

Christopher Semsarian

1 reference

22 August 2017

Rhian Shephard

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

7 August 2009

1 reference

Journal of Cardiovascular Translational Research

22 August 2017

published in

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

471-482

1 reference

https://scigraph.springernature.com/pub.10.1007/s12265-009-9120-y

22 August 2017

exact match

0 references

cites work

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Familial hypertrophic cardiomyopathy: from mutations to functional defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Sex is a potent modifier of the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-009-9120-Y

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

12 December 2020

Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice

1 reference

12 December 2020

HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study

1 reference

12 December 2020

Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice

1 reference

12 December 2020

Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy

1 reference

12 December 2020

A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Sarcomeric genotyping in hypertrophic cardiomyopathy

1 reference

12 December 2020

Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Comparison of two murine models of familial hypertrophic cardiomyopathy

1 reference

12 December 2020

A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice

1 reference

12 December 2020

The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle.

1 reference

12 December 2020

Genetic basis of hypertrophic cardiomyopathy.

1 reference

12 December 2020

Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias

1 reference

12 December 2020

Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex

1 reference

12 December 2020

An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Soy diet worsens heart disease in mice.

1 reference

12 December 2020

Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice

1 reference

12 December 2020

Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone

1 reference

12 December 2020

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart

1 reference

12 December 2020

Prevalence of the myosin-binding protein C mutation in Maine Coon cats

1 reference

12 December 2020

The effects of biological sex and diet on the development of heart failure.

1 reference

12 December 2020

Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy

1 reference

12 December 2020

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

12 December 2020

A transgenic rabbit model for human hypertrophic cardiomyopathy

1 reference

12 December 2020

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

1 reference

12 December 2020

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

1 reference

12 December 2020

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.

1 reference

12 December 2020

The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation

1 reference

12 December 2020

Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene

1 reference

12 December 2020

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy

1 reference

12 December 2020

Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder

1 reference

12 December 2020

Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction

1 reference

12 December 2020

Hypertrophic cardiomyopathy: a systematic review

1 reference

12 December 2020

Sudden death due to troponin T mutations

1 reference

12 December 2020

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

1 reference

12 December 2020

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

12 December 2020

A mouse model of familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy

1 reference

12 December 2020

The management of hypertrophic cardiomyopathy

1 reference

12 December 2020

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

1 reference

12 December 2020

Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.

1 reference

12 December 2020

Effects of two familial hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin

1 reference

12 December 2020

Multiple mutations in genetic cardiovascular disease: a marker of disease severity?

1 reference

12 December 2020

Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy

1 reference

12 December 2020

Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.

1 reference

12 December 2020

Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms

1 reference

12 December 2020

Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture.

1 reference

12 December 2020

A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation

1 reference

12 December 2020

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

1 reference

12 December 2020

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

1 reference

12 December 2020

Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments

1 reference

12 December 2020

Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy

1 reference

12 December 2020

Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death

1 reference

12 December 2020

Molecular medicine in the 21st century

1 reference

12 December 2020

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

1 reference

12 December 2020

The Genetic Basis for Cardiomyopathy

1 reference

12 December 2020

10.1007/S12265-009-9120-Y

Identifiers

DOI

1 reference

22 August 2017

1 reference